New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2013
19:05 EDTCORTCorcept Therapeutics upgraded to Overweight from Underweight at Piper Jaffray
Piper Jaffray upgraded Corcept Therapeutics two notches to Overweight from Underweight with a $4 price target after assuming coverage of the stock. Piper believes the company's increased sales efforts may result in prescription traction for its drug Korlym, which is indicated to treat Cushing’s disease.
News For CORT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CORT

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use